Cargando…

The long and still uncertain journey of BRAF as a prognostic tool in patients with papillary thyroid cancer

Detalles Bibliográficos
Autores principales:	Scheffel, Rafael Selbach, Maia, Ana Luiza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522134/ https://www.ncbi.nlm.nih.gov/pubmed/31090813 http://dx.doi.org/10.20945/2359-3997000000140

Ejemplares similares

The BRAF(V600E) mutation analysis and risk stratification in papillary thyroid carcinoma
por: Scheffel, Rafael Selbach, et al.
Publicado: (2020)

T3 therapy for hypothyroidism: choosing wisely still requires careful bench to bedside translation
por: Dora, Jose Miguel, et al.
Publicado: (2021)

Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM)
por: Ward, Laura Sterian, et al.
Publicado: (2022)

Active surveillance of papillary thyroid microcarcinomas in South America: Are we ready?
por: Danilovic, Debora Lucia Seguro, et al.
Publicado: (2019)

Intraoperative frozen section performance for thyroid cancer diagnosis
por: Goemann, Iuri Martin, et al.
Publicado: (2022)

BRAF in Papillary Thyroid Carcinoma
por: Lanzilotta, Salvatore Giovanni, et al.
Publicado: (2007)

Impact of the updated TNM staging criteria on prediction of persistent disease in a differentiated thyroid carcinoma cohort
por: Nava, Carla Fernanda, et al.
Publicado: (2019)

BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma
por: Henke, Lauren E, et al.
Publicado: (2015)

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
por: HE, GUOPING, et al.
Publicado: (2014)

BRAF Testing in Multifocal Papillary Thyroid Carcinoma
por: Kimbrell, Hillary Z., et al.
Publicado: (2015)

Navigating around the Current Options to Preserve and Regenerate Meniscus: A Long Journey Still to Be Pursued
por: Di Matteo, Berardo, et al.
Publicado: (2022)

Effect of COVID-19 pandemic on diagnosis and treatment of thyroid cancer in Brazil
por: Silveira, Vitor Bock, et al.
Publicado: (2022)

Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma
por: Zanella, André Borsatto, et al.
Publicado: (2022)

Cause of SARS still uncertain
por: Walgate, Robert
Publicado: (2003)

Risk and Prognostic Factors for BRAF(V600E) Mutations in Papillary Thyroid Carcinoma
por: Wei, Xiaojing, et al.
Publicado: (2022)

Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey
por: Sebastiani, Marco, et al.
Publicado: (2022)

The Utility of BRAF Testing in the Management of Papillary Thyroid Cancer
por: Melck, Adrienne L., et al.
Publicado: (2010)

Prognostic Significance of COX-2 Overexpression in BRAF-Mutated Middle Eastern Papillary Thyroid Carcinoma
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2020)

Prognostic Significance of BRAF V600E Mutation and CPSF2 Protein Expression in Papillary Thyroid Cancer
por: Ivković, Irena, et al.
Publicado: (2022)

BRAF and TERT mutations in papillary thyroid cancer patients of Latino ancestry
por: Estrada-Flórez, Ana P, et al.
Publicado: (2019)

Do Brazilian Pregnant Women Need Iodine Supplementation? A Commentary on the Latest American Thyroid Association Guideline
por: Severo, Mateus Dornelles, et al.
Publicado: (2017)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
por: Kim, Woon Won, et al.
Publicado: (2018)

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients with Acromegaly
por: Kim, Hee Kyung, et al.
Publicado: (2014)

The Prognostic Implication of the BRAF V600E Mutation in Papillary Thyroid Cancer in a Chinese Population
por: Ye, Ziheng, et al.
Publicado: (2022)

Construction of a Tumor Immune Microenvironment-Related Prognostic Model in BRAF-Mutated Papillary Thyroid Cancer
por: Xia, Yuxiao, et al.
Publicado: (2022)

Increasing the Radioiodine Dose Does Not Improve Cure Rates in Severe Graves' Hyperthyroidism: A Clinical Trial with Historical Control
por: Dora, Jose Miguel, et al.
Publicado: (2013)

The Still Uncertain Future of Ozone Therapy in Medicine
por: Bocci, Velio
Publicado: (2010)

Hashimoto’s Thyroiditis Minimizes Lymph Node Metastasis in BRAF Mutant Papillary Thyroid Carcinomas
por: Issa, Peter P., et al.
Publicado: (2022)

The long-term impact of COVID-19 on development assistance for health is still uncertain
por: Ogbuoji, Osondu, et al.
Publicado: (2021)

The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients
por: Yang, Li-Bo, et al.
Publicado: (2015)

BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates
por: Al-Salam, Suhail, et al.
Publicado: (2020)

Microfluidic Droplet Digital PCR Is a Powerful Tool for Detection of BRAF and TERT Mutations in Papillary Thyroid Carcinomas
por: Ylli, Dorina, et al.
Publicado: (2019)

STRA6 regulates tumor immune microenvironment and is a prognostic marker in BRAF-mutant papillary thyroid carcinoma
por: He, Weiman, et al.
Publicado: (2023)

The uncertain future
Publicado: (2015)

The Prognostic Significance of BRAF Gene Analysis in Children and Adolescents with Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis
por: Kotanidou, Eleni P, et al.
Publicado: (2023)

Clinical implication of the BRAF(V600E) mutation in papillary thyroid carcinoma
por: Kim, Yong-Seok, et al.
Publicado: (2013)

Multicentric occurrence of multiple papillary thyroid carcinomas –HUMARA and BRAF mutation analysis
por: Nakazawa, Tadao, et al.
Publicado: (2015)

Effect of BRAF mutational status on expression profiles in conventional papillary thyroid carcinomas
por: Schulten, Hans-Juergen, et al.
Publicado: (2015)

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
por: Hahn, Soo Yeon, et al.
Publicado: (2017)

The Significance of TROP2 Expression in Predicting BRAF Mutations in Papillary Thyroid Carcinoma
por: Kong, Joon Seog, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j9daqcpio2n3r2ittlc39ngi0s